加载中
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$14.775
+US$0.355 · +2.46%
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
常规交易时段
US$14.775
+US$0.355 · +2.46%
盘中时间采用ET。市场数据可能有所延迟。
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
日内区间
当前US$14.775
52周区间
当前US$14.775
盘中时间采用ET。市场数据可能有所延迟。
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
日内区间
当前US$14.775
52周区间
当前US$14.775
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 营收 | 5051.1万 USD | 2716.5万 USD | 1377.8万 USD |
| 销货成本 | 1247.1万 USD | 711.7万 USD | 387.5万 USD |
| 毛利 | 3804万 USD | 2004.8万 USD | 990.3万 USD |
| 研究与开发 | 1701.9万 USD | 1430.4万 USD | 739.5万 USD |
| 销售、一般及管理费用 | 5159.5万 USD | 2986.6万 USD | 2109.9万 USD |
| 营业费用 | 6861.4万 USD | 4417万 USD | 2849.4万 USD |
| 利息收入 | 269.8万 USD | 133万 USD | 33.4万 USD |
| 利息支出 | 143万 USD | 132.1万 USD | 64.1万 USD |
| 折旧和摊销 | 28.1万 USD | 14.5万 USD | 13.6万 USD |
| 营业利润 | −3057.4万 USD | −2412.2万 USD | −1859.1万 USD |
| 净利润 | −2963.4万 USD | −2425.7万 USD | −1889.8万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$18.50
上涨空间 25.21%评级样本有限，仅3项
报告持有此股票敞口的交易所交易基金。
iShares Russell 2000 ETFIWM311.42万0.00%787.4亿 USD0.19%US$277.93-0.36%
Vanguard Morningstar Total Stock Market ETFVTI258.33万0.00%2.3万亿 USD0.03%US$381.46-0.13%
Vanguard Extended Market ETFVXF127.42万0.00%954亿 USD0.05%US$233.52-0.63%
Vanguard Russell 2000 ETFVTWO79.61万0.00%180亿 USD0.06%US$112.27-0.35%
iShares Russell 2000 Growth ETFIWO63.06万0.00%139.17亿 USD0.24%US$353.84-0.82%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM46万0.39%1.17亿 USD0.73%US$15.86-0.50%
iShares Micro-Cap ETFIWC38.73万0.03%13.17亿 USD0.60%US$181.59-0.77%
Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSC7.55万0.09%8141.32万 USD0.69%US$36.24-0.39%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOiShares Russell 2000 Growth ETFIWOEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMiShares Micro-Cap ETFIWCRussell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
